U.S. markets closed

  • S&P 500

    4,297.50
    +5.70 (+0.13%)
     

  • Dow 30

    34,502.51
    +210.22 (+0.61%)
     

  • Nasdaq

    14,503.95
    -24.38 (-0.17%)
     

  • Russell 2000

    2,310.55
    +1.71 (+0.07%)
     

  • Crude Oil

    73.46
    +0.48 (+0.66%)
     

  • Gold

    1,770.60
    +7.00 (+0.40%)
     

  • Silver

    26.25
    +0.35 (+1.37%)
     

  • EUR/USD

    1.1864
    -0.0041 (-0.34%)
     

  • 10-Yr Bond

    1.4430
    -0.0370 (-2.50%)
     

  • GBP/USD

    1.3824
    -0.0020 (-0.15%)
     

  • USD/JPY

    111.0950
    +0.5350 (+0.48%)
     

  • BTC-USD

    34,764.08
    -1,438.57 (-3.97%)
     

  • CMC Crypto 200

    862.32
    +5.40 (+0.63%)
     

  • FTSE 100

    7,037.47
    -50.08 (-0.71%)
     

  • Nikkei 225

    28,791.53
    -21.08 (-0.07%)
     

Ovintiv Names George L. Pita to Board of Directors

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

DENVER, June 30, 2021 /PRNewswire/ - Ovintiv Inc. (NYSE: OVV) (TSX: OVV) today announced that George L. Pita has been named as an independent member of its board of directors, effective July1, 2021.

Pita, 59, currently serves as the executive vice president and chief financial officer of MasTec, Inc. (NYSE: MTZ), a leading North American infrastructure construction company. Before joining MasTec in 2013, he served in various leadership positions across multiple industries including CFO and executive vice president for Stuart Weitzman Holdings, LLC and CFO and principal accounting officer of Perry Ellis International, Inc. Pita graduated from the University of Miami, was a CPA for over 30 years, and is a member of the National Association of Corporate Directors, and the Latino Corporate Directors Association.

"We are very excited that George is joining our board. His significant business experience, diverse background and unique perspective will expand the board's strengths," said Ovintiv Chairman Peter Dea. "George's appointment builds on our thoughtful and ongoing board refreshment process."

Since early 2019, including Pita, the Company has expanded its board diversity, added five new directors, appointed a new independent board chairman and refreshed its committee memberships, including three new committee chairs.

About Ovintiv Inc.
Ovintiv is one of the largest producers of oil, condensate and natural gas in North America. The Company is committed to preserving its financial strength, maximizing profitability through disciplined capital investments and operational efficiencies and returning capital to shareholders. A talented team, in combination with a culture of innovation and efficiency, fuels Ovintiv's economic performance, increases shareholder value and strengthens its commitment to sustainability in the communities where its employees live and work.

Further information on Ovintiv Inc. is available on the Company's website, www.ovintiv.com, or by contacting:

Investor contact:

(888) 525-0304

Media contact:

(403) 645-2252

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/ovintiv-names-george-l-pita-to-board-of-directors-301323507.html

SOURCE Ovintiv Inc.

Recommended Stories

  • Why NIO Stock Is Moving Higher Today

    Shares of Chinese electric-vehicle maker NIO (NYSE: NIO) were moving higher in early trading on Wednesday, after a Wall Street analyst raised his bank's price target for the shares in a bullish note. As of 10:15 a.m. EDT, NIO's American depositary shares were up about 5.1% from Tuesday's closing price. Citibank analyst Jeff Chung raised the bank's price target on NIO to $72, from $58.30, while reiterating his previous buy rating on the shares.

  • Micron earnings and outlook top estimates, chip maker to sell Utah plant to Texas Instruments

    Micron Technology Inc. reported earnings and an outlook that surpassed Wall Street expectations in the extended session Wednesday as the chip maker announced it was selling one of its facilities to Texas Instruments Inc.

  • Morgan Stanley leads banks higher, AMD-Xilinx merger is a go, Mexico bans crypto

    Yahoo Finance’s Jared Blikre reports on the day's trending tickers.

  • Don't Blink Or You'll Miss Today's 2 Key Nasdaq Winners

    The Nasdaq Composite (NASDAQINDEX: ^IXIC) pulled back slightly from its record levels, falling about 0.1% as of 11:30 a.m. EDT today. Meme stock Bed Bath & Beyond (NASDAQ: BBBY) gave investors the latest reading on its attempts to reinvigorate the turnaround at the home goods retailer, while Advanced Micro Devices (NASDAQ: AMD) got some good news on a key strategic move it's been trying to finalize for months. Shares of Bed Bath & Beyond were up sharply on Wednesday morning, climbing 13%.

  • 15 Best Medical Stocks to Invest In

    In this article we will take a look at the 15 best medical stocks to invest in. You can skip our detailed analysis of these companies, and go directly to the 5 Best Medical Stocks to Invest In. The healthcare sector is set to grow in the coming years, as aging population, demand for life-saving […]

  • Nasdaq's banner month, hot IPO summer, Hertz shareholders cheer bankruptcy exit

    Yahoo Finance’s Jared Blikre reports on the day's trending tickers.

  • Why Novavax Stock Is Rising Today

    What happened Shares of Novavax (NASDAQ: NVAX) were up 2.3% as of 12:03 p.m. EDT on Wednesday after moving 4.2% higher earlier in the day. The company didn't report any news, so it's possible that today's gain could be in response to Altimmune (NASDAQ: ALT) throwing in the towel on its experimental nasal COVID-19 vaccine after disappointing clinical results.

  • NVIDIA's Stock Split Is Almost Here: Here's What You Should Know

    In late May, graphics chip-maker NVIDIA (NASDAQ: NVDA) surprised shareholders with an announcement that it would execute a four-for-one stock split. The stock split is finally almost here. Shares of NVIDIA have notably soared recently.

  • 3 Top Stocks That Could Triple in Price Once Again

    These stocks have been solid performers over the years, and there is a great reason why they could get even better.

  • Did Exxon Mobil's (NYSE:XOM) Share Price Deserve to Gain 40%?

    There's no doubt that investing in the stock market is a truly brilliant way to build wealth. But if when you choose to...

  • Why These 2 Moonshot Stocks Are Falling Back to Earth Wednesday

    The S&P 500 (SNPINDEX: ^GSPC) had picked up 2 points to 4,294, while the Nasdaq Composite (NASDAQINDEX: ^IXIC) had eased slightly lower by 18 points to 14,510. Shares of Virgin Galactic Holdings were down another 1% Wednesday afternoon after having been lower by as much as 8% earlier in the session. The space tourism company had seen its stock soar in the aftermath of its getting approval from the Federal Aviation Administration to take paying passengers into space, but since then, Virgin Galactic's share price has fallen close to 20% in just the past few days.

  • These 5 Bank Stocks Just Increased Their Dividends

    Based on the results of the stress tests, Bank of America (NYSE: BAC) decided to increase its quarterly dividend payment by 17% to $0.21 per share. Based on its current stock price, this translates to an annual dividend yield of just over 2%.

  • Why Shares of VBI Vaccines Soared, and Then Fell 7%, on Tuesday

    Seemingly good news from VBI Vaccines (NASDAQ: VBIV) quickly turned into trouble for shareholders during Tuesday's trading. Although COVID-19 vaccines from multiple pharma companies are available and now being widely administered, most are proving at least partially ineffective against newer strains of the virus. VBI Vaccines' work with VBI-2902a is promising in that the eVLP (enveloped virus-like particle) solution may readily target known as well as emerging strains.

  • Should Weidai (NYSE:WEI) Be Disappointed With Their 22% Profit?

    There's no doubt that investing in the stock market is a truly brilliant way to build wealth. But if when you choose to...

  • Ordinary Dividends vs. Qualified Dividends

    Dividends paid to investors by corporations come in two kinds – ordinary and qualified – and the difference has a large effect on the taxes that will be owed. Ordinary dividends are taxed as ordinary income, meaning a investor must … Continue reading → The post Ordinary Dividends vs. Qualified Dividends appeared first on SmartAsset Blog.

  • As Hertz Exits Bankruptcy, Reddit Crowd Pockets a Big Score

    (Bloomberg) -- It was seen as one of the great markers of out-of-control, irrational froth during the pandemic -- legions of amateur day traders were frantically snapping up shares of Hertz Global Holdings Inc. after it filed for bankruptcy.As the stock swelled to $5.50 last June, it made no sense to the experts. Regulators stepped in, blocking the car rental company from selling any new shares to gullible investors.On Wednesday, Hertz will exit bankruptcy. And when it does, the stock may debut

  • Why Intellia Therapeutics Was a Winner on Wednesday

    Mere days after enjoying a major stock price pop, Intellia Therapeutics (NASDAQ: NTLA) had another good day on Wednesday. In a regulatory filing, the company wrote that, "We intend to use the net proceeds from this offering to advance the clinical development of our lead programs, other pipeline candidates and the continued investment in our modular platform as well as for working capital, and other general corporate purposes." As of the end of March, it had approximately the same amount of cash, equivalents, and marketable securities on its books.

  • Investing in These Stocks Now Could Make You a Millionaire Retiree

    Finding companies that are still early in their growth path is a good technique to discover wealth-building investments. Roblox (NYSE: RBLX) and BlackLine (NASDAQ: BL) are two promising candidates that could deliver multibagger returns. Here's what you need to know before buying shares.

  • Is 23andMe a Buy at $11?

    Freshly listed on the NASDAQ following a business combination with VG Acquisition Corp, a special purpose acquisition company (SPAC), the consumer genetic-testing maven 23andMe (NASDAQ: ME) is at the very start of its growth story. In my view, this stock's growth story justifies its current price, but you'll need to hold onto it for a few years before seeing returns skyrocket. 23andMe's direct-to-consumer health service is the company's staple offering; it provides information on genetic risk factors for a handful of different diseases.

  • Inovio Has a Great Pipeline — But Is Its Stock a Buy?

    In all likelihood, the Covid-19 opportunity has passed for Inovio Phamaceuticals (INO). The DNA vaccine specialist was one of the early pacesetters last year in the race to get a coronavirus vaccine to market. However, while several peers made it past the finish line a while ago, Inovio’s program has stalled, beset by issues impeding its progress. That said, Jefferies analyst Kelechi Chikere thinks the company could potentially have a lot to offer and might be worth investors’ attention. “INO ha